دورية أكاديمية

Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion

التفاصيل البيبلوغرافية
العنوان: Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion
المؤلفون: Malarikova, DianaAff1, Aff2, Jorda, Radek, Kupcova, KristynaAff2, Aff4, Senavova, JanaAff2, Aff4, Dolnikova, Alexandra, Pokorna, Eva, Kazantsev, Dmitry, Nozickova, Kristina, Sovilj, Dana, Bellanger, Celine, Chiron, David, Andera, LadislavAff4, Aff5, Aff7, Krystof, Vladimir, Strnad, Miroslav, Helman, Karel, Klanova, MagdalenaAff1, Aff2, Trneny, Marek, Havranek, OndrejAff2, Aff4, Klener, PavelAff1, Aff2, IDs40164024004992_cor19
المصدر: Experimental Hematology & Oncology. 13(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:21623619
DOI:10.1186/s40164-024-00499-2